COVID-19 Pediatric Dermatology
| dc.contributor.author | Neale, Holly | |
| dc.contributor.author | Hawryluk, Elena B. | |
| dc.date | 2022-08-11T08:08:11.000 | |
| dc.date.accessioned | 2022-08-23T15:45:18Z | |
| dc.date.available | 2022-08-23T15:45:18Z | |
| dc.date.issued | 2021-10-01 | |
| dc.date.submitted | 2021-09-02 | |
| dc.identifier.citation | <p>Neale H, Hawryluk EB. COVID-19 Pediatric Dermatology. Dermatol Clin. 2021 Oct;39(4):505-519. doi: 10.1016/j.det.2021.05.012. Epub 2021 May 31. PMID: 34556241; PMCID: PMC8165089.</p> | |
| dc.identifier.doi | 10.1016/j.det.2021.05.012 | |
| dc.identifier.pmid | 34556241 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/27497 | |
| dc.description.abstract | Children are a unique subset of patients in relation to the COVID-19 pandemic, often presenting asymptomatically, mildly, or atypically. Manifestations of the skin may be a primary (or the only) presenting sign. Recognizing cutaneous manifestations of COVID-19 in the pediatric population is important to guiding precautions, testing, and management for patients and close contacts. Whereas some dermatologic signs in children overlap with those in adults, other skin findings are reported with higher frequency in children and may be clues to multisystemic sequelae. This article describes presentation, pathophysiologic theories, and management strategies for cutaneous manifestations of COVID-19 in children. | |
| dc.language.iso | en_US | |
| dc.relation | <p><a href="https://pubmed.ncbi.nlm.nih.gov/34556241/" target="_blank" title="view article in PubMed">View article in PubMed</a></p> | |
| dc.relation.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165089/ | |
| dc.subject | MIS-C | |
| dc.subject | Pediatric dermatology | |
| dc.subject | COVID-19 children | |
| dc.subject | Perniosis | |
| dc.subject | Pernio-like lesions | |
| dc.subject | Dermatology | |
| dc.subject | Infectious Disease | |
| dc.subject | Pediatrics | |
| dc.subject | Skin and Connective Tissue Diseases | |
| dc.subject | Virus Diseases | |
| dc.title | COVID-19 Pediatric Dermatology | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Dermatologic Clinics | |
| dc.source.volume | 39 | |
| dc.source.issue | 4 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/covid19/299 | |
| dc.identifier.contextkey | 24635909 | |
| html.description.abstract | <p>Children are a unique subset of patients in relation to the COVID-19 pandemic, often presenting asymptomatically, mildly, or atypically. Manifestations of the skin may be a primary (or the only) presenting sign. Recognizing cutaneous manifestations of COVID-19 in the pediatric population is important to guiding precautions, testing, and management for patients and close contacts. Whereas some dermatologic signs in children overlap with those in adults, other skin findings are reported with higher frequency in children and may be clues to multisystemic sequelae. This article describes presentation, pathophysiologic theories, and management strategies for cutaneous manifestations of COVID-19 in children.</p> | |
| dc.identifier.submissionpath | covid19/299 | |
| dc.contributor.department | School of Medicine | |
| dc.source.pages | 505-519 |
Files in this item
Name:
Publisher version